!Drugs
_are
_classified
_in
_various
_ways
_.
_One
!of
_the
_key
*divisions
_is
_by
_level
!of
_control
_,
_which
_distinguishes
!prescription
!drugs
_(
_those
_that
*a
!pharmacist
!dispenses
_only
_on
_the
_order
!of
*a
!physician
_,
!physician
_assistant
_,
_or
_qualified
!nurse
_)
_from
_over-the-counter
!drugs
_(
_those
_that
_consumers
_can
_order
_for
_themselves
_)
_.
_Another
_key
*distinction
_is
_between
_traditional
*small-molecule
!drugs
_,
_usually
_derived
_from
!chemical
_synthesis
_,
_and
!biopharmaceuticals
_,
_which
_include
!recombinant
!proteins
_,
!vaccines
_,
!blood
!products
_used
!therapeutically
_(
_such
_as
!IVIG
_)
_,
!gene
!therapy
_,
!monoclonal
!antibodies
_and
*cell
!therapy
_(
_for
_instance
_,
!stem-cell
!therapies
_)
_.
_Other
_ways
_to
_classify
!medicines
_are
_by
_mode
!of
_action
_,
_route
!of
_administration
_,
!biological
_system
_affected
_,
_or
!therapeutic
!effects
_.
_An
_elaborate
_and
_widely
_used
_classification
_system
_is
_the
*Anatomical
!Therapeutic
!Chemical
*Classification
!System
_(
!ATC
_system
_)
_.
_The
*World
!Health
!Organization
_keeps
*a
_list
!of
_essential
!medicines
_.
!Drug
_discovery
_and
_drug
_development
_are
_complex
_and
!expensive
_endeavors
_undertaken
*by
_pharmaceutical
_companies
_,
!academic
_scientists
_,
_and
_governments
!.
!As
_a
_result
_of
*this
!complex
!path
_from
_discovery
_to
_commercialization
!,
*partnering
!has
_become
!a
_standard
_practice
_for
_advancing
!drug
_candidates
_through
_development
!pipelines
_.
_Governments
_generally
_regulate
_what
_drugs
_can
_be
_marketed
_,
_how
_drugs
*are
_marketed
_,
_and
*in
!some
_jurisdictions
_,
_drug
_pricing
!.
_Controversies
_have
_arisen
!over
_drug
_pricing
_and
!disposal
!of
_used
!drugs
_.
!Drugs
_are
_classified
!in
_various
_ways
_.
!One
_of
_the
_key
_divisions
_is
_by
_level
!of
_control
_,
*which
_distinguishes
!prescription
_drugs
_(
_those
_that
_a
_pharmacist
_dispenses
!only
_on
_the
_order
_of
_a
_physician
_,
!physician
_assistant
_,
!or
_qualified
_nurse
_)
_from
_over-the-counter
_drugs
_(
!those
!that
_consumers
_can
_order
_for
_themselves
_)
_.
!Another
_key
_distinction
_is
_between
_traditional
_small-molecule
_drugs
!,
!usually
_derived
_from
_chemical
_synthesis
_,
_and
_biopharmaceuticals
!,
!which
_include
_recombinant
_proteins
_,
_vaccines
_,
_blood
!products
_used
!therapeutically
_(
_such
_as
_IVIG
_)
_,
_gene
!therapy
_,
_monoclonal
!antibodies
!and
!cell
_therapy
_(
_for
_instance
_,
_stem-cell
_therapies
!)
_.
!Other
_ways
_to
_classify
_medicines
_are
_by
_mode
!of
_action
_,
*route
_of
_administration
_,
!biological
_system
_affected
_,
_or
!therapeutic
!effects
_.
_An
_elaborate
*and
!widely
!used
_classification
_system
_is
_the
!Anatomical
*Therapeutic
!Chemical
_Classification
!System
_(
_ATC
_system
_)
!.
_The
_World
_Health
!Organization
_keeps
_a
_list
_of
_essential
_medicines
_.
!Drug
_discovery
_and
_drug
_development
_are
_complex
_and
!expensive
_endeavors
_undertaken
*by
_pharmaceutical
_companies
_,
!academic
_scientists
_,
_and
_governments
_.
_As
_a
!result
_of
_this
*complex
_path
_from
_discovery
!to
_commercialization
_,
!partnering
_has
_become
_a
_standard
_practice
_for
_advancing
!drug
_candidates
_through
*development
_pipelines
_.
!Governments
_generally
_regulate
_what
_drugs
_can
_be
_marketed
!,
_how
_drugs
*are
_marketed
_,
_and
!in
_some
_jurisdictions
_,
!drug
_pricing
_.
_Controversies
_have
_arisen
_over
_drug
!pricing
_and
_disposal
*of
_used
_drugs
_.
!Drugs
_are
_classified
!in
_various
_ways
_.
!One
_of
_the
_key
_divisions
_is
_by
_level
!of
_control
_,
*which
_distinguishes
!prescription
_drugs
_(
_those
_that
_a
_pharmacist
_dispenses
!only
_on
_the
_order
_of
_a
_physician
_,
!physician
_assistant
_,
!or
_qualified
_nurse
_)
_from
_over-the-counter
_drugs
_(
!those
!that
_consumers
_can
_order
_for
_themselves
_)
_.
!Another
_key
_distinction
_is
_between
_traditional
_small-molecule
_drugs
!,
!usually
_derived
_from
_chemical
_synthesis
_,
_and
_biopharmaceuticals
!,
!which
_include
_recombinant
_proteins
_,
_vaccines
_,
_blood
!products
_used
!therapeutically
_(
_such
_as
_IVIG
_)
_,
_gene
!therapy
_,
_monoclonal
!antibodies
!and
!cell
_therapy
_(
_for
_instance
_,
_stem-cell
_therapies
!)
_.
!Other
_ways
_to
_classify
_medicines
_are
_by
_mode
!of
_action
_,
*route
_of
_administration
_,
!biological
_system
_affected
_,
_or
!therapeutic
!effects
_.
_An
_elaborate
*and
!widely
!used
_classification
_system
_is
_the
!Anatomical
*Therapeutic
!Chemical
_Classification
!System
_(
_ATC
_system
_)
!.
_The
_World
_Health
!Organization
_keeps
_a
_list
_of
_essential
_medicines
_.
!Drug
_discovery
_and
_drug
_development
_are
_complex
_and
!expensive
_endeavors
_undertaken
*by
_pharmaceutical
_companies
_,
!academic
_scientists
_,
_and
_governments
_.
_As
_a
!result
_of
_this
*complex
_path
_from
_discovery
!to
_commercialization
_,
!partnering
_has
_become
_a
_standard
_practice
_for
_advancing
!drug
_candidates
_through
*development
_pipelines
_.
!Governments
_generally
_regulate
_what
_drugs
_can
_be
_marketed
!,
_how
_drugs
*are
_marketed
_,
_and
!in
_some
_jurisdictions
_,
!drug
_pricing
_.
_Controversies
_have
_arisen
_over
_drug
!pricing
_and
_disposal
*of
_used
_drugs
_.
!Drugs
_are
_classified
!in
_various
_ways
_.
!One
_of
_the
_key
_divisions
_is
_by
_level
!of
_control
_,
*which
_distinguishes
!prescription
_drugs
_(
_those
_that
_a
_pharmacist
_dispenses
!only
_on
_the
_order
_of
_a
_physician
_,
!physician
_assistant
_,
!or
_qualified
_nurse
_)
_from
_over-the-counter
_drugs
_(
!those
!that
_consumers
_can
_order
_for
_themselves
_)
_.
!Another
_key
_distinction
_is
_between
_traditional
_small-molecule
_drugs
!,
!usually
_derived
_from
_chemical
_synthesis
_,
_and
_biopharmaceuticals
!,
!which
_include
_recombinant
_proteins
_,
_vaccines
_,
_blood
!products
_used
!therapeutically
_(
_such
_as
_IVIG
_)
_,
_gene
!therapy
_,
_monoclonal
!antibodies
!and
!cell
_therapy
_(
_for
_instance
_,
_stem-cell
_therapies
!)
_.
!Other
_ways
_to
_classify
_medicines
_are
_by
_mode
!of
_action
_,
*route
_of
_administration
_,
!biological
_system
_affected
_,
_or
!therapeutic
!effects
_.
_An
_elaborate
*and
!widely
!used
_classification
_system
_is
_the
!Anatomical
*Therapeutic
!Chemical
_Classification
!System
_(
_ATC
_system
_)
!.
_The
_World
_Health
!Organization
_keeps
_a
_list
_of
_essential
_medicines
_.
!Drug
_discovery
_and
_drug
_development
_are
_complex
_and
!expensive
_endeavors
_undertaken
*by
_pharmaceutical
_companies
_,
!academic
_scientists
_,
_and
_governments
_.
_As
_a
!result
_of
_this
*complex
_path
_from
_discovery
!to
_commercialization
_,
!partnering
_has
_become
_a
_standard
_practice
_for
_advancing
!drug
_candidates
_through
*development
_pipelines
_.
!Governments
_generally
_regulate
_what
_drugs
_can
_be
_marketed
!,
_how
_drugs
*are
_marketed
_,
_and
!in
_some
_jurisdictions
_,
!drug
_pricing
_.
_Controversies
_have
_arisen
_over
_drug
!pricing
_and
_disposal
*of
_used
_drugs
_.
!Drugs
_are
_classified
!in
_various
_ways
_.
!One
_of
_the
_key
_divisions
_is
_by
_level
!of
_control
_,
*which
_distinguishes
!prescription
_drugs
_(
_those
_that
_a
_pharmacist
_dispenses
!only
_on
_the
_order
_of
_a
_physician
_,
!physician
_assistant
_,
!or
_qualified
_nurse
_)
_from
_over-the-counter
_drugs
_(
!those
!that
_consumers
_can
_order
_for
_themselves
_)
_.
!Another
_key
_distinction
_is
_between
_traditional
_small-molecule
_drugs
!,
!usually
_derived
_from
_chemical
_synthesis
_,
_and
_biopharmaceuticals
!,
!which
_include
_recombinant
_proteins
_,
_vaccines
_,
_blood
!products
_used
!therapeutically
_(
_such
_as
_IVIG
_)
_,
_gene
!therapy
_,
_monoclonal
!antibodies
!and
!cell
_therapy
_(
_for
_instance
_,
_stem-cell
_therapies
!)
_.
!Other
_ways
_to
_classify
_medicines
_are
_by
_mode
!of
_action
_,
*route
_of
_administration
_,
!biological
_system
_affected
_,
_or
!therapeutic
!effects
_.
_An
_elaborate
*and
!widely
!used
_classification
_system
_is
_the
!Anatomical
*Therapeutic
!Chemical
_Classification
!System
_(
_ATC
_system
_)
!.
_The
_World
_Health
!Organization
_keeps
_a
_list
_of
_essential
_medicines
_.
!Drug
_discovery
_and
_drug
_development
_are
_complex
_and
!expensive
_endeavors
_undertaken
*by
_pharmaceutical
_companies
_,
!academic
_scientists
_,
_and
_governments
_.
_As
_a
!result
_of
_this
*complex
_path
_from
_discovery
!to
_commercialization
_,
!partnering
_has
_become
_a
_standard
_practice
_for
_advancing
!drug
_candidates
_through
*development
_pipelines
_.
!Governments
_generally
_regulate
_what
_drugs
_can
_be
_marketed
!,
_how
_drugs
*are
_marketed
_,
_and
!in
_some
_jurisdictions
_,
!drug
_pricing
_.
_Controversies
_have
_arisen
_over
_drug
!pricing
_and
_disposal
*of
_used
_drugs
_.
